Molecule

ROSUVASTATIN
SEGMENTATION

 PATIENT SEGMENTATION
In dyslipidemic patients with low HDL

 THERAPEUTIC SEGMENTATION
HMGCoA Reductase inhibitor
TARGETING
 Cardiologists
 MD (Medicine)
DIFFERENTIATION

 Cytochrome P-450 inhibitor Technology - Gives

increased bioavailibility.
POSITIONING

 The only statin that causes significant

improvement in HDL levels
 Reduces risk of venous thromboembolism
BRAND NAME

ROSUVASTAR
 BRAND COMMUNICATION

HOW WOULD I
WHO AM I? WHAT CAN I DO
MAKE U FEEL?
FOR YOU?

• CONFIDENT AND
• BEST
HAPPY THAT I
• ROSUVASTAR IMPROVEMENT IN
CAN LEAD A
HDL LEVELS
• COMPETITOR TO LONGER AND
THAN OTHER
LIPITOR STRESS FREE LIFE
STATINS
• ANTI- WITH MY FAMILY
• BEST REDUCTION
HYPERLIPIDEMIC • INCREASED
IN LDL LEVELS
AGENT CONFIDENCE AND
• STELLAR TRIAL
STAMINA AT
PROVES WORKPLACE.
EFFICIENCY
Brand extension
 Brand extension

 Active ingredients(molecules)-
 ROSUVASTATIN 10mg+ FENOFIBRATE-160mg

 Brand name
 ROSUFEN
SEGMENTATION

 PATIENT SEGMENTATION
 IN PATIENTS WITH MIXED DYSLIPIDEMIA
AND LOW HDL

 THERAPEUTIC SEGMENTATION
 HMGCoA REDUCTASE INHIBITOR
TARGETING
 CARDIOLOGIST
 DIABETOLOGIST
POSITIONING
 POSITIONING
 THE MOST EFFECTIVE COMBINATION
(STATIN+FIBRATE) IN LONGTERM
TREATMENT AND CONTROL OF MIXED
DYSLIPIDEMIA
 Differentiation
 Differentiation-

 Film coated tablet which leads to better

bioavailibility and efficacy.
 BRAND COMMUNICATION

HOW WOULD I
WHO AM I? WHAT CAN I DO
MAKE U FEEL?
FOR YOU?

• CONFIDENT AND
• BEST
HAPPY THAT I
• ROSUVAFEN IMPROVEMENT IN
CAN LEAD A
TRIGLYCERIDE
• COMPETITOR TO LONGER AND
LEVELS THAN
STATOR-F STRESS FREE LIFE
OTHER STATINS
• ANTI- WITH MY FAMILY
• BEST
HYPERLIPIDEMIC • INCREASED
IMPROVEMENT IN
AGENT CONFIDENCE AND
HDL LEVELS
STAMINA AT
• PROVEN
WORKPLACE.
CLINICAL
EFFICIENCY